Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T00:56:47.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-19T17:17:26.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-12T13:18:09.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:54:38.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:55:28.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed information about a clinical trial involving the IDO1 inhibitor BMS-986205 and nivolumab for treating liver cancer, while adding new identifiers and collaborators related to the study.
    Difference
    47%
    Check dated 2025-04-16T02:07:29.000Z thumbnail image

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.